Summary
Ornithine transcarbamylase deficiency is an X-linked disease with possible manifestations in heterozygous females. Using segregation analysis in families from the literature pooled with a French series, the penetrance could be estimated to be 17% in heterozygous females (15% with severe and 2% with milder symptoms). Using these estimates, the proportion of sporadic cases among heterozygous females and hemizygous males could be derived. This proportion is 57% in females. In males, it depends on mutation rate values: assuming equal mutation rates in sperm and eggs, this proportion should be 40%. However, this value can be strongly rejected based on the proportion of isolated cases in male sibships. In both sets of data, segregation analysis provided no evidence for sporadic affected males, suggesting that there are virtually no mutations in eggs. The upper limit of the confidence interval, 0%–16%, can be taken as the maximum prior probability that an affected male occurs as the result of a new mutation in his mother's germ cells.
Similar content being viewed by others
References
Batshaw ML, Msall M, Beaudet AL, Trojak J (1986) Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency. J Pediatr 108:236–241
Haldane JBS (1935) The rate of spontaneous mutations of a human gene. J Genet 13:317–326
Jackson MJ, Beaudet AL, O'Brien WE (1986) Mammalian urea cycle enzymes. Annu Rev Genet 20:431–464
Morton NE (1959) Genetic tests under incomplete ascertainment. Am J Hum Genet 11:1–16
Morton NE, Lalouel JM (1977) Genetic epidemiology of Lesch-Nyhan disease (Letter to the editor). Am J Hum Genet 29:304–307
Morton NE, Lalouel JM (1979) Genetic counseling in sex linkage. Birth Defects 15:9–24
Pelet A, Rotig A, Bonaïti-Pellié C, Rabier D, Cormier V, Toumas E, Hentzen D, Saudubray JM, Munnich A (1990) Carrier detection in a partially dominant X-linked disease: ornithine transcarbamylase deficiency. Hum Genet 84:167–171
Rowe PC, Newman SL, Brusilow SW (1986) Natural history of symptomatic partial ornithine transcarbamylase deficiency. N Engl J Med 314:541–547
Sherman SL, Morton NE, Jacobs PA, Turner G (1984) The marker (X) syndrome: a cytogenetic analysis. Ann Hum Genet 48:21–37
Vogel F (1977) A probable sex difference in some mutation rates. Am J Hum Genet 29:312–319
Vogel F, Rathenberg R (1975) Spontaneous mutation in man. Adv Hum Genet 5:223–318
Walser M (1983) Urea cycle disorders and other hereditary hyperammonemic syndromes. In: Stanbury JB, Wingaarden JB, Frederickon DS, Goldstein JL, Braun MS (eds) The metabolic basis of inherited disease, 5th edn. McGraw-Hill, New York, pp 409–419
Wettke-Schäfer R, Kantner G (1983) X-linked dominant inherited diseases with lethality in hemizygous males. Hum Genet 64:1–23
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonaïti-Pellié, C., Pelet, A., Ogier, H. et al. A probable sex difference in mutation rates in ornithine transcarbamylase deficiency. Hum Genet 84, 163–166 (1990). https://doi.org/10.1007/BF00208933
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00208933